← Leaderboards
Conan Kinsey
University Of Utah
$1,364,720
Attributed
$1,364,720
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $272.9K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,364,720 · 1
By mechanism
K08$1,364,720 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- Gurkan Mollaoglu$439,082
- Jinchuan Xing$2,696,814
- Lewis C Murtaugh$5,738,542
- Amanda Truong$136,410
- Debra S Regier$144,008
Others in their field
Other Emerging Leaders on “Cellular Assay”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Yunda Huang · Fred Hutchinson Cancer Center$19,715,358
Research focus
Cellular AssayAurora Kinase AAdvanced Pancreatic CancerAntitumor EffectBasic ScienceBiochemical ProcessAutophagocytosisBiologyBackBiopsy SpecimenBromodomainBypassCancer BiologyCancer CellCancer Cell LineBiochemistryCancer EtiologyCancer InitiationCareerCdk4 GeneCell CycleCell LineCellsCellular Biology
Grant awards (5)
Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer$272,944
K08 · FY2024 · CA · contact PI
Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer$272,944
K08 · FY2023 · CA · contact PI
Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer$272,944
K08 · FY2022 · CA · contact PI
Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer$272,944
K08 · FY2021 · CA · contact PI
Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer$272,944
K08 · FY2020 · CA · contact PI